Memorandum of Understanding Revised Annex Between the Food and Drug Administration and the Russian Federation

Короткий зміст

The Food and Drug Administration (FDA) is providing notice of a Revised Annex to a Memorandum of Understanding Between the FDA and the Russian Federation. The purpose of the Revised Annex is to reaffirm their cooperation under the principles of cooperation established in the MOU initially effective February 15, 1994, and to clarify and expand the procedures for registration under this MOU. The purpose of the initial MOU is to exchange information on drugs and biological products and to facilitate the development of the Russian health care sector by establishing in Russia a streamlined registration procedure for U.S. drugs and biological products.